VCEL FY 2012 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,000+16.7% YoY

Gross Profit

$15,00071.4% margin

Operating Income

-$34M-160761.9% margin

Net Income

-$29M-140352.4% margin

EPS (Diluted)

$-14.31

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$15M

Total Liabilities

$6M

Stockholders' Equity

$10M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,000	$18,000	+16.7%
Gross Profit	$15,000	$14,000	+7.1%
Operating Income	-$34M	-$29M	-16.3%
Net Income	-$29M	-$20M	-49.9%